Research.Patient.info

Pre-Heart Failure (Non-diabetic) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic exploratory (Phase II)
The impact of Empagliflozin on Left atrIal Volume and the feasibility of using Fitbit and mHealth to prescribe Exercise in non-diabetic Pre- Heart Failure (ELIVE pre-HF Study)
This study looks at how a medicine called Empagliflozin might help people with early heart weakening by checking changes in a heart chamber. It also explores using Fitbits to help people exercise more, aiming to improve heart health before full heart failure develops.
Ireland